Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;15(2):153-161.
doi: 10.25122/jml-2021-0108.

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis

Affiliations
Review

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis

Anna Baranova et al. J Med Life. 2022 Feb.

Abstract

Breast cancer is the most common cancer in women and the most common cause of death in working-age women. According to the results of immunohistochemical studies, 10-20% of cases revealed a triple-negative type of breast cancer. This subtype is characterized by significant proliferative activity and growth rate, aggressive clinical course, and early metastasis. This leads to a suspicious prognosis and, accordingly, encourages an increase of surgical treatment radicalism and aggressive systemic treatment. This review briefly analyzes existing treatment strategies for triple-negative breast cancer with a focus on surgical treatment. Surgical treatment is an integral part of complex therapy. Currently, the attention of researchers is focused not only on the radicalism of the operation, ensuring long-term survival, but also on achieving a good cosmetic result that determines the quality of life of patients. In this aspect, organ-preserving and prosthetic methods of operations are promising, the feasibility and effectiveness of which are being discussed. The relevance of choosing the optimal method of operation is evidenced by the lack of generally accepted approaches based on informative markers for the prognosis of the course of the disease. Therefore, the choice of the optimal method of surgical treatment taking into account the individual characteristics of the patient and the tumor, indications for chemotherapy, and radiation therapy remains an unresolved issue and requires further research.

Keywords: ACT – adjuvant chemotherapy; AR – androgen receptors; ART – adjuvant radiation therapy; BC – breast cancer; BMI – body mass index; CT– chemotherapy; ER – estrogen receptors; IHC – immunohistochemical; LN – lymph node; NACT – neoadjuvant chemotherapy; RM – radical mastectomy; TNBC – triple-negative breast cancer; breast cancer; late result; organ-preserving operations; radical mastectomy; surgical treatment; triple-negative type.

PubMed Disclaimer

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016;7(S3):43–6. doi: 10.7314/apjcp.2016.17.s3.43. - DOI - PubMed
    1. Wang H, Naghavi M, Allen C, Barber RM, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
    1. Wang Q, Xu M, Sun Y, Chen J, et al. Gene expression profiling for diagnosis of triple-negative breast cancer: a multicenter, retrospective cohort study. Front Oncol. 2019;9:354. doi: 10.3389/fonc.2019.00354. - DOI - PMC - PubMed
    1. Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016;293(2):247–69. doi: 10.1007/s00404-015-3859-y. - DOI - PubMed